{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T11:57:54Z","timestamp":1742644674518},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Interleukin-17F (IL-17F), one of the cytokines, is crucial in the pathophysiology of juvenile idiopathic arthritis (JIA). Therefore, we aimed to determine the relation between IL17F 7488A\/G and IL17F 7383A\/G single-nucleotide polymorphisms and JIA susceptibility and to explain their impact on the disease activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Genomic DNA of 70 patients with JIA and 70 age and sex-matched controls were extracted and typed for IL17F 7488A\/G and IL17F 7383A\/G single-nucleotide polymorphisms, using polymerase chain reaction with sequence-specific primers method, and compared between patients and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>When compared to AA participants, children with the AG genotype of the IL17F 7488A\/G and IL17F 7383A\/G polymorphisms showed a substantially greater risk of JIA. Furthermore, children with the G allele were 2.8 folds more likely to have JIA than the A allele for IL17F 7488A\/G polymorphism and 3.72 folds for IL17F 7383A\/G polymorphism. Children with AG genotype of IL17F 7383A\/G polymorphism were far more likely to have high activity JIA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The G allele of both IL17F 7488A\/G and IL17F7383 A\/G polymorphisms is associated with increased JIA susceptibility, and JIA at High Disease Activity was more likely to develop in AG subjects of the IL17F 7383 A\/G polymorphism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>The relationship between Interleukin-17F 7488A\/G and 7383A\/G polymorphisms and risk for JIA has not been recognized before.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Impact of Interleukin-17F 7488A\/G and 7383A\/G genotypes on JIA disease activity.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The G allele of both IL17F 7488A\/G and IL17F7383 A\/G polymorphisms are associated with increased JIA susceptibility.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>AG genotype of Interleukin-17F 7383 A\/G polymorphism compared to AA patients, had a higher probability of developing JIA at a High Disease Activity (HDA) level.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-022-02288-1","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:15:42Z","timestamp":1662452142000},"page":"1496-1502","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between Interleukin-17F 7488A\/G and 7383A\/G polymorphisms and susceptibility to juvenile idiopathic arthritis"],"prefix":"10.1038","volume":"94","author":[{"given":"Eman Rateb","family":"Abd Almonaem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf Mohamed","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira M. N.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha Mohamed","family":"Daay El Khair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omima Mohamed","family":"Abdel Haie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2288_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/acr.23870","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold, S. et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care Res. (Hoboken) 71, 717\u2013734 (2019).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"2288_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty, R. E. et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31, 390\u2013392 (2004).","journal-title":"J. Rheumatol."},{"key":"2288_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ocl.2019.06.003","volume":"50","author":"KM Bovid","year":"2019","unstructured":"Bovid, K. M. & Moore, M. D. Juvenile idiopathic arthritis for the pediatric orthopedic surgeon. Orthop. Clin. North Am. 50, 471\u2013488 (2019).","journal-title":"Orthop. Clin. North Am."},{"key":"2288_CR4","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","volume":"184","author":"SR Pickens","year":"2010","unstructured":"Pickens, S. R. et al. IL-17 contributes to angiogenesis in rheumatoid arthritis. J. Immunol. 184, 3233\u20133241 (2010).","journal-title":"J. Immunol."},{"key":"2288_CR5","first-page":"912","volume":"28","author":"JC M\u00f6ller","year":"2010","unstructured":"M\u00f6ller, J. C. et al. IL10 promoter polymorphisms are associated with systemic-onset juvenile idiopathic arthritis (SoJIA). Clin. Exp. Rheumatol. 28, 912\u2013918 (2010).","journal-title":"Clin. Exp. Rheumatol."},{"key":"2288_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/rheumatology\/34.5.454","volume":"34","author":"M Rooney","year":"1995","unstructured":"Rooney, M. et al. Inflammatory cytokine responses in juvenile chronic arthritis. Br. J. Rheumatol. 34, 454\u2013460 (1995).","journal-title":"Br. J. Rheumatol."},{"key":"2288_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/art.20198","volume":"50","author":"AA Grom","year":"2004","unstructured":"Grom, A. A. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 50, 689\u2013698 (2004).","journal-title":"Arthritis Rheum."},{"key":"2288_CR8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman, D. et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369\u20131376 (1998).","journal-title":"J. Clin. Invest."},{"key":"2288_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"LA Tesmer","year":"2008","unstructured":"Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87\u2013113 (2008).","journal-title":"Immunol. Rev."},{"key":"2288_CR10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/art.38647","volume":"66","author":"C Piper","year":"2014","unstructured":"Piper, C. et al. T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity. Arthritis Rheumatol. (Hoboken, N. J.) 66, 1955\u20131960 (2014).","journal-title":"Arthritis Rheumatol. (Hoboken, N. J.)"},{"key":"2288_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/ard.2010.143768","volume":"70","author":"A Hot","year":"2011","unstructured":"Hot, A. & Miossec, P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann. Rheum. Dis. 70, 727\u2013732 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"2288_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40259-014-0098-x","volume":"28","author":"S Adami","year":"2014","unstructured":"Adami, S., Cavani, A., Rossi, F. & Girolomoni, G. The role of interleukin-17A in psoriatic disease. BioDrugs 28, 487\u2013497 (2014).","journal-title":"BioDrugs"},{"key":"2288_CR13","first-page":"1206","volume":"31","author":"O Cinek","year":"2004","unstructured":"Cinek, O. et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J. Rheumatol. 31, 1206\u20131210 (2004).","journal-title":"J. Rheumatol."},{"key":"2288_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/1529-0131(200104)44:4<802::AID-ANR136>3.0.CO;2-G","volume":"44","author":"RP Donn","year":"2001","unstructured":"Donn, R. P. et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group. Arthritis Rheum. 44, 802\u2013810 (2001).","journal-title":"Arthritis Rheum."},{"key":"2288_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/rheumatology\/keh689","volume":"44","author":"K Oen","year":"2005","unstructured":"Oen, K. et al. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatol. (Oxf.) 44, 1115\u20131121 (2005).","journal-title":"Rheumatol. (Oxf.)"},{"key":"2288_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/iji.12152","volume":"41","author":"M Mahmoudi","year":"2014","unstructured":"Mahmoudi, M. et al. Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int. J. Immunogenet. 41, 512\u2013517 (2014).","journal-title":"Int. J. Immunogenet."},{"key":"2288_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10067-015-2877-2","volume":"34","author":"A Rezaei","year":"2015","unstructured":"Rezaei, A. et al. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin. Rheumatol. 34, 1059\u20131064 (2015).","journal-title":"Clin. Rheumatol."},{"key":"2288_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.humimm.2009.01.027","volume":"70","author":"S Jim\u00e9nez-Morales","year":"2009","unstructured":"Jim\u00e9nez-Morales, S. et al. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum. Immunol. 70, 251\u2013256 (2009).","journal-title":"Hum. Immunol."},{"key":"2288_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1684\/ecn.2014.0352","volume":"25","author":"V Ziaee","year":"2014","unstructured":"Ziaee, V. et al. Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur. Cytokine Netw. 25, 35\u201340 (2014).","journal-title":"Eur. Cytokine Netw."},{"key":"2288_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0022-3859.52846","volume":"55","author":"KS Puri","year":"2009","unstructured":"Puri, K. S., Suresh, K. R., Gogtay, N. J. & Thatte, U. M. Declaration of Helsinki, 2008: implications for stakeholders in research. J. Postgrad. Med. 55, 131\u2013134 (2009).","journal-title":"J. Postgrad. Med."},{"key":"2288_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro, A. et al. Development, and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 61, 658\u2013666 (2009).","journal-title":"Arthritis Rheum."},{"key":"2288_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/rheumatology\/kev414","volume":"55","author":"A Consolaro","year":"2016","unstructured":"Consolaro, A. & Ravelli, A. Defining criteria for disease activity states in juvenile idiopathic arthritis. Rheumatol. (Oxf., Engl.) 55, 595\u2013596 (2016). vol.","journal-title":"Rheumatol. (Oxf., Engl.)"},{"key":"2288_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman, T. et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken) 63, 465\u2013482 (2011). 2011.","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"2288_CR24","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace, C. A., Ruperto, N. & Giannini, E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J. Rheumatol. 31, 2290\u20132294 (2004).","journal-title":"J. Rheumatol."},{"key":"2288_CR25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3899\/jrheum.100930","volume":"38","author":"G Filocamo","year":"2011","unstructured":"Filocamo, G. et al. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report. J. Rheumatol. 38, 938\u2013953 (2011).","journal-title":"J. Rheumatol."},{"key":"2288_CR26","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/rheumatology\/keaa240","volume":"59","author":"J Tibaldi","year":"2020","unstructured":"Tibaldi, J. et al. Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis. Rheumatology 59, 3505\u20133514 (2020).","journal-title":"Rheumatology"},{"key":"2288_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3899\/jrheum.180331","volume":"46","author":"B Saccomanno","year":"2019","unstructured":"Saccomanno, B. et al. Predictors of effectiveness of anakinra in systemic juvenile idiopathic arthritis. J. Rheumatol. 46, 416\u2013421 (2019).","journal-title":"J. Rheumatol."},{"key":"2288_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/aje\/kwn359","volume":"169","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez, S., Gaunt, T. R. & Day, I. N. M. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 169, 505\u2013514 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"2288_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00005-014-0319-5","volume":"63","author":"K Bogunia-Kubik","year":"2015","unstructured":"Bogunia-Kubik, K. et al. IL-17A, IL-17F and IL-23R gene polymorphisms in polish patients with rheumatoid arthritis. Arch. Immunol. Ther. Exp. (Warsz.). 63, 215\u2013221 (2015).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)."},{"key":"2288_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaci.2005.12.1346","volume":"117","author":"M Kawaguchi","year":"2006","unstructured":"Kawaguchi, M. et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J. Allergy Clin. Immunol. 117, 795\u2013801 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2288_CR31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1365-2222.2006.02550.x","volume":"36","author":"N Hizawa","year":"2006","unstructured":"Hizawa, N., Kawaguchi, M., Huang, S.-K. & Nishimura, M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol. 36, 1109\u20131114 (2006).","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"key":"2288_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/rheumatology\/ken512","volume":"48","author":"GBN Nordang","year":"2009","unstructured":"Nordang, G. B. N. et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatol. (Oxf.) 48, 367\u2013370 (2009).","journal-title":"Rheumatol. (Oxf.)"},{"key":"2288_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3109\/08916934.2012.702814","volume":"45","author":"N Yan","year":"2012","unstructured":"Yan, N. et al. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity 45, 533\u2013539 (2012).","journal-title":"Autoimmunity"},{"key":"2288_CR34","doi-asserted-by":"publisher","first-page":"258293","DOI":"10.1155\/2012\/258293","volume":"2012","author":"Y Quan","year":"2012","unstructured":"Quan, Y. et al. Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin. Dev. Immunol. 2012, 258293 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"2288_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5606\/ArchRheumatol.2019.7000","volume":"34","author":"P Chen","year":"2019","unstructured":"Chen, P., He, G., Yang, Y., Yang, Y. & Li, L. Association of interleukin-17F 7488A\/G and 7383A\/G polymorphisms with rheumatoid arthritis: a meta-analysis. Arch. Rheumatol. 34, 148\u2013156 (2019).","journal-title":"Arch. Rheumatol."},{"key":"2288_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.imlet.2017.01.013","volume":"183","author":"OS Marwa","year":"2017","unstructured":"Marwa, O. S., Kalthoum, T., Wajih, K. & Kamel, H. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment. Immunol. Lett. 183, 24\u201336 (2017).","journal-title":"Immunol. Lett."},{"key":"2288_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-3083.2010.02411.x","volume":"72","author":"A Paradowska-Gorycka","year":"2010","unstructured":"Paradowska-Gorycka, A. et al. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand. J. Immunol. 72, 134\u2013141 (2010).","journal-title":"Scand. J. Immunol."},{"key":"2288_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/annrheumdis-2014-eular.5482","volume":"73","author":"K Demircan","year":"2014","unstructured":"Demircan, K. et al. AB0067 IL-17F gene polymorphism correlated with longer disease duration of rheumatoid arthritis patients. Ann. Rheum. Dis. 73, 826 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"2288_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1064-1","volume":"17","author":"A Pawlik","year":"2016","unstructured":"Pawlik, A. et al. IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis. BMC Musculoskelet. Disord. 17, 208 (2016).","journal-title":"BMC Musculoskelet. Disord."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02288-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:03:27Z","timestamp":1697799807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02288-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The current study was approved by the Medical Research Ethical Committee of the Faculty of Medicine, Benha University. All subjects were informed about the procedures and the aim of the study and informed written consent was obtained from the parents or caregivers of enrolled children. The committee\u2019s reference number is not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}